SALA, BARBARA
 Distribuzione geografica
Continente #
NA - Nord America 4.312
AS - Asia 2.915
EU - Europa 2.385
SA - Sud America 365
AF - Africa 72
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 15
Totale 10.080
Nazione #
US - Stati Uniti d'America 4.022
SG - Singapore 1.142
CN - Cina 666
DE - Germania 442
IT - Italia 431
HK - Hong Kong 332
RU - Federazione Russa 319
VN - Vietnam 281
BR - Brasile 279
SE - Svezia 272
UA - Ucraina 265
CA - Canada 240
IE - Irlanda 234
GB - Regno Unito 118
FR - Francia 110
IN - India 98
FI - Finlandia 68
KR - Corea 61
BD - Bangladesh 56
ID - Indonesia 40
TR - Turchia 34
IR - Iran 31
MX - Messico 27
PL - Polonia 27
ES - Italia 24
ZA - Sudafrica 24
AR - Argentina 23
JP - Giappone 23
IQ - Iraq 22
PK - Pakistan 22
BE - Belgio 18
PH - Filippine 18
NL - Olanda 17
SA - Arabia Saudita 16
VE - Venezuela 15
CO - Colombia 13
EU - Europa 13
CL - Cile 11
NZ - Nuova Zelanda 11
DK - Danimarca 10
TN - Tunisia 10
EC - Ecuador 9
KE - Kenya 9
CH - Svizzera 8
IL - Israele 8
MY - Malesia 8
PY - Paraguay 8
EG - Egitto 7
KZ - Kazakistan 7
MA - Marocco 7
TH - Thailandia 7
AE - Emirati Arabi Uniti 6
AT - Austria 6
NP - Nepal 5
AU - Australia 4
ET - Etiopia 4
JM - Giamaica 4
JO - Giordania 4
LT - Lituania 4
NG - Nigeria 4
OM - Oman 4
UZ - Uzbekistan 4
AL - Albania 3
DO - Repubblica Dominicana 3
HN - Honduras 3
KG - Kirghizistan 3
LB - Libano 3
NI - Nicaragua 3
SY - Repubblica araba siriana 3
UY - Uruguay 3
A1 - Anonimo 2
AO - Angola 2
AZ - Azerbaigian 2
BO - Bolivia 2
GE - Georgia 2
LY - Libia 2
MD - Moldavia 2
PA - Panama 2
PE - Perù 2
TT - Trinidad e Tobago 2
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
GP - Guadalupe 1
GR - Grecia 1
GT - Guatemala 1
KW - Kuwait 1
MM - Myanmar 1
MN - Mongolia 1
MR - Mauritania 1
MT - Malta 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
Totale 10.076
Città #
Singapore 708
Ashburn 379
Ann Arbor 324
Hong Kong 310
Woodbridge 298
Jacksonville 253
San Jose 253
Dublin 227
Chandler 221
Houston 185
Frankfurt am Main 163
Dearborn 161
Milan 156
Toronto 153
Beijing 119
New York 117
Fairfield 107
Santa Clara 92
Princeton 84
Ho Chi Minh City 77
Nanjing 75
Council Bluffs 71
The Dalles 66
Wilmington 65
Los Angeles 62
Boardman 60
Chicago 56
Dallas 53
Hanoi 47
Seattle 44
Buffalo 42
Lachine 42
Seoul 42
Shanghai 40
Cambridge 38
Lauterbourg 38
Dong Ket 34
Jakarta 29
Munich 28
Hefei 25
Guangzhou 24
Tehran 23
Altamura 20
Nanchang 20
Orem 20
Shenyang 20
Chennai 19
Moscow 19
São Paulo 19
Brussels 18
Jinan 18
Nürnberg 18
Rome 18
Lawrence 17
Helsinki 16
Tianjin 15
Changsha 14
Montreal 14
San Diego 13
Zhengzhou 13
Atlanta 12
Columbus 12
Fremont 12
Stockholm 12
Andover 11
Brooklyn 11
Kraków 11
Kunming 11
London 11
Mountain View 11
Rio de Janeiro 11
Tokyo 11
Warsaw 11
Bergamo 10
Denver 10
Falls Church 10
Istanbul 10
Jiaxing 10
Ningbo 10
Phoenix 10
Carate Brianza 9
Lahore 9
St Louis 9
Turku 9
Baghdad 8
Can Tho 8
Cape Town 8
Dhaka 8
Jeddah 8
Leawood 8
Ottawa 8
Santiago 8
Turin 8
Amsterdam 7
Cagliari 7
Haiphong 7
Lissone 7
Manchester 7
Nairobi 7
Norwalk 7
Totale 6.076
Nome #
Oxidative stress and altered mitochondrial dynamics in neurodegenerative processes 432
Neutrophil depletion affects Dark Agouti Experimental Autoimmune Encephalomyelitis 367
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 339
Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse 302
In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™) 297
MSCs ameliorate clinical course in rats with experimental autoimmune encephalomyelitis 294
Exposure-response relationship of the synthetic epothilone sagopilone in a peripheral neurotoxicity rat model 291
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells 284
Effectiveness of MSC therapeutic administration on rats affected by chronic Experimental Autoimmune Encephalomyelitis 279
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 272
Positive effect of Mesenchymal Stem Cells therapeutic administration on chronic Experimental Autoimmune Encephalomyelitis 266
Caratterizzazione neurofisiologica, neuropatologica e comportamentale della neuropatia periferica da Bortezomib in moldelli murini 261
MSCs effect on Dark Agouti rats affected by chronic EAE 258
Characterization in vivo of two different molecular mechanisms involved in the development of bortezomib-induced peripheral neuropathy 258
Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy 257
Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies 254
Characterization of bortezomib-induced peripheral neuropathy in an immune-suppressed murine model 252
Neutrophil depletion during sensitization phase affects the chronic phase of Experimental Autoimmune Encephalomyelitis 250
Organic cation transporter 2 mRNA expression in dorsal root ganglia neurons 248
Lipoplatin tm: a less neurotoxic formulation of cisplatin 246
Antibody Against Tumor Necrosis Factor-α Reduces Bortezomib-induced Allodynia in a Rat Model 245
Paclitaxel: Chemotherapy and Neurotoxicity – The Two sides of the Coin 244
BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY: STUDY OF PROTEASOME INHIBITION AND MICROTUBULE STABILIZATION MECHANISMS IN RAT MODEL 237
Preventive treatment with anti-rat neutrophil serum affects the relapsing phase in Dark Agouti EAE rats 237
Multimodal Comparison of Diabetic Neuropathy in Aged Streptozotocin-Treated Sprague–Dawley and Zucker Diabetic Fatty Rats 234
Pain-related behaviour and analgesic effect of gabapentin in an experimental model of bortezomib-induced neuropathic pain 227
Morphometrical characterization of DRG alterations induced by cisplatin and bortezomib in several mice models 219
Cisplatin-induced painful peripheral neuropathy severity is strain-dipendent in mice: dissecting the role of pharmacogenomics. 211
Neurotoxicity induced by cisplatin, taxol and bortezomib in immunocompetent cd1 mice and immunodeficient nude mice 209
Peripheral neuropathy induced by chronic administration of cisplatin, taxol and bortezomib in several murine models 207
STUDY OF THE CALCITONIN GENE-RELATED PEPTIDE-POSITIVE INTRAEPIDERMAL NERVE FIBERS IN A RAT MODEL OF BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY 206
Biodistrubution and toxicology of two PFCs intravenously injected in rats 205
electrophysiological, behavioural and morphological characterization of oxaliplatin-induced painful peripheral neuropathy in mice 205
L-serine supplementation suppresses the formation of neurotoxic deoxysphingolipids and improves neuropathy in a type 1 diabetic rat model 204
EXPRESSION OF TRPV1 AND CGRP IN SPINAL PRIMARY AFFERENT NEURONS IN A RAT MODEL OF BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY TREATED WITH ANALGESICS 200
CISPLATIN, EPOTHILONE B AND BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHIES: A NEUROPHYSIOLOGICAL STUDY IN THE MOUSE. 199
Characterization of the neurotoxicity and antineoplastic activity of bortezomib in a new myeloma-bearing murine model. 193
Evaluation of the neuroprotective effect of acetyl-l-carnitine in myeloma-bearing mice treated with bortezomib 186
CHARACTERIZATION OF PERIPHERAL NEUROPATHY INDUCED BY CHRONIC CISPLATIN ADMINISTRATION IN SEVERAL MICE MODELS 171
Platinum derivaties-induced peripheral neuropathy 167
Influence of aging on peripheral nervous system: a morphological and morphometric study 165
Imidazoline Receptor 2 is an Effective Target for Neuropathic Pain in a Murine Model of Bortezomib-Induced Peripheral Neuropathy 158
CHARACTERIZATION OF NEW MURINE MODELS OF PERIPHERAL NEUROPATHY INDUCED BY CHRONIC ADMINISTRATION OF ANTINEOPLASTIC COMPOUNDS 67
Totale 10.303
Categoria #
all - tutte 31.063
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.063


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202148 0 0 0 0 0 0 0 0 0 0 0 48
2021/2022337 4 31 16 24 32 32 17 31 16 30 16 88
2022/2023873 107 253 83 85 38 143 2 49 77 4 14 18
2023/2024689 18 21 12 22 108 190 124 26 34 16 11 107
2024/20251.547 99 243 111 84 124 33 63 55 191 198 127 219
2025/20263.872 432 185 271 286 382 281 552 215 365 337 284 282
Totale 10.303